Mitochondrial dysfunction and cellular metabolic deficiency in Alzheimer’s disease
Mitochondrial dysfunction and cellular metabolic deficiency in Alzheimer’s disease
复制标题
DOI:
10.1007/s12264-012-1270-2
复制
发表时间:
2012-09
影响因子:
5.6
通讯作者:
Xue-mei Gu;Han-Chang Huang;Zhao-feng Jiang
中科院分区:
文献类型:
--
作者:
Xue-mei Gu;Han-Chang Huang;Zhao-feng Jiang
Alzheimer’s disease (AD) is an age-related neurodegenerative disorder. The pathology of AD includes amyloid-β (Aβ) deposits in neuritic plaques and neurofibrillary tangles composed of hyperphosphorylated tau, as well as neuronal loss in specific brain regions. Increasing epidemiological and functional neuroimaging evidence indicates that global and regional disruptions in brain metabolism are involved in the pathogenesis of this disease. Aβ precursor protein is cleaved to produce both extracellular and intracellular Aβ, accumulation of which might interfere with the homeostasis of cellular metabolism. Mitochondria are highly dynamic organelles that not only supply the main energy to the cell but also regulate apoptosis. Mitochondrial dysfunction might contribute to Aβ neurotoxicity. In this review, we summarize the pathways of Aβ generation and its potential neurotoxic effects on cellular metabolism and mitochondrial dysfunction.